Strs Ohio Angion Biomedica Corp. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$1.1 - $2.23 $21,560 - $43,708	-19,600 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$2.35 - $9.95 $37,365 - $158,205	-15,900 Reduced 44.79%	19,600 $56,000
Q2 2021 Jul 26, 2021	BUY	$13.02 - $17.83 $443,982 - $608,003	34,100 Added 2435.71%	35,500 $462,000
Q1 2021 Apr 23, 2021	BUY	$15.01 - $25.74 $21,014 - $36,036	1,400 New	1,400 $25,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.